Health & Fitness No, Johnson & Johnson’s Vaccine Isn’t “Less Effective” — Here’s Why

13:46  05 march  2021
13:46  05 march  2021 Source:   msn.com

Half-dose of Oxford vaccine was NOT a 'mistake', scientists say

  Half-dose of Oxford vaccine was NOT a 'mistake', scientists say Oxford University's researchers have insisted they knew about the different dosing regimens and agreed everything with regulators before people were given the injectionsIn a hit back against claims that the team had accidentally given people the wrong doses of the vaccine, the researchers said they had known the doses would be smaller because of a manufacturing issue before they injected them.

a plastic water bottle © Provided by Refinery29 A vial of the Johnson & Johnson Janssen Covid-19 vaccine at Northwell Health South Shore University Hospital in Bay Shore, New York, U.S., on Wednesday, March 3, 2021. President Biden said that Merck & Co. will help make Johnson & Johnson’s single-shot coronavirus vaccine, a collaboration between rivals aimed at ramping up the pace of inoculations that will help provide enough supply for every adult in the U.S. by the end of May. Photographer: Johnny Milano/Bloomberg via Getty Images

Nationwide, people are grappling with the weight of life during the coronavirus pandemic as they reflect on an entire year living under some kind of lockdown. For many, the pandemic has meant working from home, less physical contact with family and friends, and a complete change in how they interact with everyday life in an effort to keep themselves and their loved ones safer from the deadly virus.

A Guide To The Covid-19 Vaccine If You're Pregnant Or Breastfeeding

  A Guide To The Covid-19 Vaccine If You're Pregnant Or Breastfeeding People who are either pregnant and deemed high-risk from Covid-19, or breastfeeding, have now been given the go-ahead to have the Covid-19 vaccine in the UK – despite previously being told they shouldn’t have it. Although it seems like positive news, there hasn’t been a change in evidence in terms of the safety of such vaccines for these groups. It’s likely to be a confusing U-turn for those who were explicitly told they couldn’t have the vaccine and were gearing up to batten down the hatches for months while carrying their baby, and possibly years after, if breastfeeding.So what do you need to know?Related...

But there is some hope for relief, now that a third vaccine has been approved by the Food and Drug Administration (FDA) for emergency use in the US. Johnson & Johnson has also applied for approval in the UK. Johnson & Johnson’s single-dose COVID-19 vaccine is now being administered across the United States for people ages 18 and older. Despite the fact that there are now even more vaccines being made available to millions of people across the country, some are skeptical that the J&J vaccine is less effective than the Moderna and Pfizer two-dose vaccines, due to lower efficacy numbers.

Media reports on the new vaccine have focused their attention on its efficacy rate: 72% for Johnson & Johnson, compared to 94% for Moderna and 95% for Pfizer. But the lower rate shouldn’t discourage anyone from getting the single-dose vaccine, which is equally as effective as the other two at preventing serious illness, according to The New York Times. The J&J vaccine’s lower effectiveness number refers only to its ability to prevent all infections as a result of contracting the SARS-Cov-2 virus.

Quick guide: COVID-19 vaccines in use and how they work

  Quick guide: COVID-19 vaccines in use and how they work Here's a guide to the vaccines being used in different countries.Dozens of coronavirus vaccines entered clinical trials during 2020, and now, a handful have been authorized for emergency use in various countries — meaning the shots can be administered to the public while their developers continue to collect data on their safety and efficacy. Should they meet all the necessary criteria, these vaccines could be fully approved in the future, and in some places, they already have been.

While it may not be as good at preventing mild COVID cases, Johnson & Johnson’s single dose is just as successful as the other two at preventing the most serious cases of this virus, and that’s most important. For more context, the Johnson & Johnson vaccine is also more effective than the flu jab. According to the Centers for Disease Control and Prevention (CDC), “flu vaccination reduces the risk of flu illness by between 40% and 60% among the overall population during seasons when most circulating flu viruses are well-matched to the flu vaccine.”

Gallery: Early signs of multiple sclerosis (Espresso)

a man with his mouth open: Around 6% of people who have multiple sclerosis also experience hearing-related problems, according to the National MS Society. In very rare instances, this symptom can be the first reported sign of MS in patients. The cause of this hearing loss may be damage in the nerve pathways within the brain. If you have any type of hearing issue, make sure to have it checked by a medical professional.

Dr Robert Wachter, chair of the department of medicine at the University of California, San Francisco told The New York Times that with any of the three vaccines, “There’s essentially no chance you will die of COVID, which is breathtaking.” This is notable, considering the virus has killed more than half a million people in the US over the last year.

Covid vaccine: Can you still transmit Covid after full vaccination?

  Covid vaccine: Can you still transmit Covid after full vaccination? COVID vaccination programmes have provided 10 million Brits with their first dose, with more 20 percent of the country soon to adopt some form of immunity against coronavirus. Can you still transmit Covid after full vaccination? Full vaccination with one of the available candidates should afford people protection from 90 percent or more Covid cases.Ultimately, this will prevent people from catching severe cases of the virus, bringing the death rate down.But scientists still want to know whether inoculated people can spread the disease to others.

The goal of any of the three vaccines is not to completely root out COVID-19, which is likely here to stay. Instead, the hope is to turn the virus into something like a mild flu or the common cold while we seek to achieve herd immunity and in that regard, things are looking up.

“When you think of what do you want from a vaccine, you don’t want to go to the hospital, and you certainly don’t want to die,” Johnson & Johnson CEO and Chairman Alex Gorsky told CNBC’s Squawk Box. “And what we have seen as far as 100% efficacy in those parameters, again with a single shot.”

Experts say they would recommend any of the three vaccines and suggest that people get whichever one is first made available to them. That is our best possible tool when it comes to moving past the pandemic. Lisa Lee, an infectious disease epidemiologist and public health ethicist at Virginia Tech, said last month that a third vaccine option “substantially reduces the time it takes the US to reach herd immunity.” Lee also noted that as more of the population becomes vaccinated, there is less opportunity for further mutations of the virus to develop. “When we stop transmitting between people, we also stop the opportunity for mutation,” she told CNBC.

After a long year in relative isolation, as people sit with the grief of losing their old ways of living and their loved ones and the uncertainty of what comes next, it’s only natural that they might question the efficacy of a new vaccine. We’ve been dealt so many blows in the last year, after all. But rest assured that if your time comes for the vaccine and the Johnson & Johnson single-dose job is made available to you, it’s just one more layer of protection for all of us.

Scott Morrison secures 20million more doses of Pfizer vaccine .
The vaccines - taking Australia's Pfizer jab total to 40 million - are due to arrive in the final three months of 2021. On Thursday night the government received advice from its scientists that the Pfizer vaccine was preferred in adults under 50 because of evidence from Europe that the AstraZeneca vaccines causes blood clots in extremely rare cases. © Provided by Daily Mail Australia has ordered 20million more doses of the Pfizer vaccine after the AstraZeneca vaccine was linked to potentially deadly bloodclots Australia had relied heavily on the AstraZeneca vaccine with 53.8million doses ordered.

usr: 5
This is interesting!